This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letter to the Editor

Paroxetine for Primary Insomnia: Possible Placebo Effect?

Mahmoud N. Musa

Published: November 30, 1999

Article Abstract

Letter to the Editor

Sir: Primary insomnia is widely prevalent, resulting in considerable distress and impairment. A new drug that is not a controlled substance, is nonhabituating, and that does not leave the patient sedated during the day would be a welcome addition to the pharmacopoeia. I read with interest the article by Nowell et al., which reported an uncontrolled, open study of the treatment of primary insomnia with the selective serotonin reuptake inhibitor antidepressant paroxetine in 14 patients.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: